DCN, as an inhibitor of TGF-β1 and an activator of the VEGF pathway, may promote the occurrence and development of OLP by suppressing the expression of TGF-β1 and increasing VEGF expression to facilitate angiogenesis. Here, TGFB1 is linked to oral lichen planus.